<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04912050</url>
  </required_header>
  <id_info>
    <org_study_id>2020-03</org_study_id>
    <nct_id>NCT04912050</nct_id>
  </id_info>
  <brief_title>EXtension of Tablo TrEatmeNt Duration Registry</brief_title>
  <acronym>XTEND</acronym>
  <official_title>EXtension of Tablo TrEatmeNt Duration Registry (XTEND)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Outset Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Outset Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational, retrospective and prospective, multicenter, post-market study of the Tablo&#xD;
      Hemodialysis System in hospitalized participants with End-Stage Kidney Disease or Acute&#xD;
      Kidney Injury who are prescribed renal replacement therapy &gt; 12 hours.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 25, 2021</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Treatment Success</measure>
    <time_frame>Up to 24 hours</time_frame>
    <description>Percentage of treatments achieving prescribed dialysis treatment time ≤ 10%</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tablo Cartridge Life</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>Measure the average number of cartridge changes required to complete a Tablo XT Treatment</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>End Stage Renal Disease (ESRD)</condition>
  <condition>End Stage Renal Disease on Dialysis</condition>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>Tablo Hemodialysis System</arm_group_label>
    <description>Hospitalized participants with End-Stage Kidney Disease or Acute Kidney Injury who are prescribed renal replacement therapy &gt; 12 hours on the Tablo Hemodialysis System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tablo Hemodialysis System</intervention_name>
    <description>Renal Replacement Therapy between 12&lt; to ≤ 24 hours.</description>
    <arm_group_label>Tablo Hemodialysis System</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Hospitalized participants with End-Stage Kidney Disease or Acute Kidney Injury who are&#xD;
        prescribed renal replacement therapy &gt; 12 hours.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participant weighs ≥ 34kg.&#xD;
&#xD;
          -  Participant is hospitalized and has dialysis dependent End-Stage Kidney Disease or&#xD;
             Acute Kidney Injury and is prescribed renal replacement therapy &gt; 12 hours.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any documented condition that the Physician feels would prevent the participant from&#xD;
             successful inclusion in the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Josh Schumacher</last_name>
    <phone>(669) 231-8200</phone>
    <email>ClinicalTeam@outsetmedical.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>St. Mark's Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84124</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kasadi Moore, RN</last_name>
    </contact>
    <investigator>
      <last_name>Tahir Zaman, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>May 26, 2021</study_first_submitted>
  <study_first_submitted_qc>May 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 3, 2021</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tablo</keyword>
  <keyword>Outset Medical</keyword>
  <keyword>Hemodialysis</keyword>
  <keyword>AKI</keyword>
  <keyword>ESKD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Only aggregated participant data is planned to be shared at this time.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

